Showing results (51-60 of 67) with videos related to
Sort By:
Pageof 7
Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.Leukemia & Lymphoma|October 17, 2015
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphomaPhilip A Thompson, Travis Perera, David Marin, et al.Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.Blood|April 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissionsSasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, et al.The Lancet. Haematology|August 12, 2019
Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 studyFarhad Ravandi, Rita Assi, Naval Daver, et al.Pathology|March 18, 2023
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphomaSiba El Hussein, L Jeffrey Medeiros, Kirill A Lyapichev, et al.Cancer|April 1, 2021
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Nicholas J Short, et al.Blood Advances|December 14, 2022
Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemiaChaitra Ujjani, Ted A Gooley, Stephen E Spurgeon, et al.Blood Cancer Discovery|February 12, 2026
Ibrutinib with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia: A phase II studyMahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson, et al.Blood|April 16, 2025
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation: the ERIC RecommendationsAdam S Kittai, Monia Marchetti, Othman Al-Sawaf, et al.Pageof 7